Heilen Cross Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.25 M
- Company Age 25 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.30 M
- Satisfied Charges ₹ 1.87 Cr
- Revenue Growth 53.81%
- Profit Growth 52.47%
- Ebitda 53.84%
- Net Worth 5.75%
- Total Assets 8.36%
About Heilen Cross Diagnostics
Heilen Cross Diagnostics Private Limited (HCDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 June 1999 and has a history of 25 years and seven months. Its registered office is in Kolkata, West Bengal, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.25 M.
The company currently has active open charges totaling ₹1.30 M. The company has closed loans amounting to ₹1.87 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sunita Kandoi, Vinod Kandoi, Parma Rungta, and One other member serve as directors at the Company.
Company Details
-
Location
Kolkata, West Bengal, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U85195WB1999PTC089638
-
Company No.
089638
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jun 1999
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at Heilen Cross Diagnostics?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunita Kandoi
|
Director | 21-Sep-2010 | Current |
|
Vinod Kandoi
|
Director | 05-Sep-2003 | Current |
|
Parma Rungta
|
Whole-Time Director | 01-Sep-2014 | Current |
|
Amit Rungta
|
Director | 16-Jun-1999 | Current |
Financial Performance of Heilen Cross Diagnostics.
Heilen Cross Diagnostics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.81% increase. The company also saw a substantial improvement in profitability, with a 52.47% increase in profit. The company's net worth moved up by a moderate rise of 5.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Heilen Cross Diagnostics?
In 2022, Heilen Cross Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Rajnigandha Towers LlpSunita Kandoi and Vinod Kandoi are mutual person
-
Kandoi Securities Pvt Ltd
Sunita Kandoi and Vinod Kandoi are mutual person
-
Pragya Consultants Llp
Vinod Kandoi is a mutual person
-
Pragya Projects Ltd.
Vinod Kandoi and Amit Rungta are mutual person
-
Suryakiran Apartment Services Pvt Ltd
Vinod Kandoi is a mutual person
-
Vivid Fashions Pvt Ltd.
Parma Rungta is a mutual person
Charges (Loans)
₹1.30 M
₹18.72 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Aug 2022 | Hdfc Bank Limited | ₹1.30 M | Open |
| 24 Nov 2020 | Hdfc Bank Limited | ₹4.10 M | Satisfied |
| 22 Apr 2016 | Hdfc Bank Limited | ₹5.05 M | Satisfied |
| 22 Sep 2014 | Hdfc Bank Limited | ₹2.01 M | Satisfied |
| 23 Mar 2013 | Hdfc Bank Limited | ₹3.56 M | Satisfied |
How Many Employees Work at Heilen Cross Diagnostics?
Heilen Cross Diagnostics has a workforce of 43 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Heilen Cross Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Heilen Cross Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.